Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 13/20 | 0.42 |
| ▸ | CTSS | P25774 | 4/20 | 0.40 |
| ▸ | SYK | P43405 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16512842 | 0.87 | CTSK (0.41) | CTSKCTSSSYKCA1CA2 | |
| SCHEMBL20064066 | 0.87 | CTSK (0.44) | CTSKCTSSSYKCA1CA2 | |
| SCHEMBL27542782 | 0.86 | CTSK (0.51) | CTSKCTSS | |
| Hydrochloric Acid SCHEMBL27541055 | 0.84 | CTSK (0.50) | CTSKCTSS | |
| SCHEMBL28470420 | 0.84 | CTSK (0.50) | CTSKCTSS | |
| SCHEMBL28879680 | 0.84 | CTSK (0.50) | CTSKCTSS | |
| SCHEMBL18122641 | 0.84 | CTSK (0.50) | CTSKCTSS | |
| SCHEMBL28166713 | 0.84 | CTSK (0.50) | CTSKCTSS | |
| SCHEMBL23515315 | 0.84 | CTSK (0.56) | CTSKCTSS | |
| SCHEMBL25735228 | 0.84 | CTSK (0.56) | CTSKCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018069863-A1 | 1,3 DI-SUBSTITUTED CYCLOBUTANE OR AZETIDINE DERIVATIVES AS HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE INHIBITORS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2018-04-19 | — | — | WO | disclosed |